Testing effectiveness (Phase 2)Looking for participantsNCT05940493What this trial is testingAbemaciclib in Newly Diagnosed Meningioma PatientsWho this might be right forMeningioma Nader Sanai 72
Not applicableStudy completedNCT00112593What this trial is testingFludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+176 more Fred Hutchinson Cancer Center 5
Early research (Phase 1)Study completedNCT03833180What this trial is testingZilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001)Who this might be right forChronic Lymphocytic LeukemiaMantle Cell LymphomaFollicular Lymphoma+9 more VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 91
Early research (Phase 1)Study completedNCT00769288What this trial is testingFAU in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+57 more National Cancer Institute (NCI) 12
Early research (Phase 1)Study completedNCT00104923What this trial is testingFenretinide in Treating Patients With Refractory or Relapsed Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+1 more California Cancer Consortium 29
Testing effectiveness (Phase 2)Looking for participantsNCT06533579What this trial is testingGene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)Who this might be right forB-cell Acute Lymphoblastic LeukemiaLarge B-cell LymphomaChronic Lymphocytic Leukemia+10 more Vironexis Biotherapeutics Inc. 32
Testing effectiveness (Phase 2)Study completedNCT00027560What this trial is testingMelphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more Memorial Sloan Kettering Cancer Center 51
Early research (Phase 1)Study completedNCT00020462What this trial is testingVaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III, Stage IV, or Recurrent Follicular LymphomaWho this might be right forLymphoma National Cancer Institute (NCI)
Not applicableLooking for participantsNCT05255354What this trial is testingOptimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR TherapyWho this might be right forFollicular LymphomaDiffuse Large B Cell LymphomaMantle Cell Lymphoma Adaptive Biotechnologies 300
Not applicableUnknownNCT04870853What this trial is testingCardiovascular Events Among Adults Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Standard of Care Chimeric Antigen Receptor T Cell TherapyWho this might be right forRecurrent Aggressive B-Cell Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent High Grade B-Cell Lymphoma+7 more M.D. Anderson Cancer Center 150
Early research (Phase 1)Ended earlyNCT02454270What this trial is testingA Dose Escalation Study of Duvortuxizumab in Participants With Relapsed or Refractory B-cell MalignanciesWho this might be right forLeukemia, Lymphocytic, Chronic, B-CellLymphoma, Large B-Cell, DiffuseLymphoma, Follicular+2 more Janssen Research & Development, LLC 59
Testing effectiveness (Phase 2)Study completedNCT01427881What this trial is testingCyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+65 more Fred Hutchinson Cancer Center 43
Not applicableStudy completedNCT02520895What this trial is testingImmunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic LeukemiaWho this might be right forLYMPHOMA Hospices Civils de Lyon 98
Testing effectiveness (Phase 2)UnknownNCT00740467What this trial is testingStem Cell Transplant in Treating Patients With Hematological Cancer or Other DisordersWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Institut Paoli-Calmettes 50
Testing effectiveness (Phase 2)UnknownNCT05627427What this trial is testingMulti-cohort Study of Surufatinib Plus Sintilimab in Metastatic NEN and Pancreatic Carcinoma Who Failed Standard ChemotherapyWho this might be right forNeuroendocrine Tumor Grade 3Neuroendocrine CarcinomaPancreatic Carcinoma Tianjin Medical University Cancer Institute and Hospital 60
Early research (Phase 1)WithdrawnNCT02238522What this trial is testingPhase 1 Study Evaluating ZEN003365 in Relapsed/Refractory Lymphoproliferative Malignancies or Relapsed/Refractory AMLWho this might be right forLymphoproliferative MalignanciesAcute Myeloid Leukemia Zenith Epigenetics
Very early researchStudy completedNCT00017381What this trial is testingMonoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forContiguous Stage II Adult Diffuse Large Cell LymphomaContiguous Stage II Adult Diffuse Small Cleaved Cell LymphomaContiguous Stage II Grade 1 Follicular Lymphoma+47 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Looking for participantsNCT07468136What this trial is testingRetifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade GliomasWho this might be right forAnaplastic OligodendrogliomaAstrocytoma, IDH-Mutant, Grade 3Astrocytoma, IDH-Mutant, Grade 4+3 more Mayo Clinic 33
Early research (Phase 1)Ended earlyNCT00538187What this trial is testingObatoclax and Bortezomib in Treating Patients With Aggressive Relapsed or Recurrent Non-Hodgkin LymphomaWho this might be right forAdult Non-Hodgkin LymphomaRecurrent Adult Diffuse Large Cell LymphomaRecurrent Grade 1 Follicular Lymphoma+5 more National Cancer Institute (NCI) 18
Not applicableUnknownNCT02279277What this trial is testingPhysical Therapy Prior to Total Knee ReplacementWho this might be right forOsteoarthritis of the Hip Rothman Institute Orthopaedics 148